Diabetes drugs linked to slower frailty progression in older adults
A new study shows that older adults with type 2 diabetes who start treatment with sodium–glucose cotransporter-2 (SGLT-2)…
WHO releases first guideline on the use of GLP-1 therapies for treating obesity
To address the growing global health challenge of obesity, which affects more than 1 billion people, the World Health…
Tirzepatide may only temporarily suppress brain activity involved in “food noise”
A rare glimpse into the brain activity of a patient with obesity and loss of control eating on…
WHO reviews highlight limited long-term data on GLP-1 drug safety
Three new Cochrane reviews find evidence that GLP-1 drugs result in clinically meaningful weight loss, but industry-funded studies…
Diabetes remission possible with GLP-1 drugs, Italian study confirms
Real-world data from over 14,000 Italian adults reveal that GLP-1 receptor agonists can induce remission in type 2…
Scientists unveil new obesity drug that reprograms fat and energy use
Details of a new drug that aims to treat the underlying causes of obesity are being presented at…
Exercise found to reduce artery hardening after weight loss in adults with obesity
Maintaining weight loss with regular exercise rather than the glucagon-like peptide-1 receptor agonist (GLP-1RA) liraglutide, a drug used…